Papadas, A., Huang, Y., Cicala, A., Dou, Y., Fields, M., Gibbons, A., Hong, D., Lagal, D.J., Quintana, V., Rizo, A., Zomalan, B. and Asimakopoulos, F. (2023) Emerging roles for tumor stroma in antigen presentation and anti-cancer immunity. Biochem. Soc. Trans.51: 2017–2028. doi: https://doi.org/10.1042/BST20221083
The authors would like to correct a passage of text from the “Dual roles of a non-cellular stromal actor: the contrast between the immunoregulatory proteoglycan versican versus its immunostimulatory proteolytic fragment, versikine” section of their review.
The original text reads:
Mice with targeted disruption of the Glu441-Ala442 bond that generates versikine demonstrate developmental abnormalities (94, 99). In wound healing, disruption of the Glu441-Ala442 bond, thus generating versikine from VCAN-V1, attenuates inflammation and promotes healing (94).
This should instead read:
Mice with targeted disruption of the Glu441-Ala442 cleavage site that generates versikine demonstrate developmental abnormalities (94, 99). In wound healing, disruption of the Glu441-Ala442 cleavage site, thus abrogating versikine generation from VCAN-V1, attenuates inflammation and promotes healing (94).
The requested correction has been assessed and agreed by the Editorial Board.
